The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
 
 
 
 

Infection in the elderly: studies with lomefloxacin.

Results of trials of lomefloxacin (400 mg once daily) in elderly patients with uncomplicated urinary tract infections, complicated urinary tract infections, acute bacterial exacerbations of chronic bronchitis, and as prophylaxis for transurethral surgical procedures (400 mg single dose) have been analyzed. In patients greater than or equal to 65 years of age with uncomplicated urinary tract infections, the bacterial eradication rate for lomefloxacin was 100%. In patients with complicated urinary tract infections, the bacterial eradication rate for lomefloxacin (92.2%) was statistically superior to comparator agents (84.9%, p = 0.012). In elderly patients with acute exacerbations of chronic bronchitis caused predominantly by gram-negative pathogens, lomefloxacin eradicated 85.2% of pathogens versus 73.8% for amoxicillin (p = 0.004). Lomefloxacin was 98% effective as a prophylactic agent in transurethral surgery. The bacteriologic and clinical efficacy of lomefloxacin was similar in young and elderly groups of patients. Lomefloxacin appears to be as effective as the comparator drugs in both young and elderly patients.[1]

References

  1. Infection in the elderly: studies with lomefloxacin. Crome, P., Bruce-Jones, P. Am. J. Med. (1992) [Pubmed]
 
WikiGenes - Universities